Who can take PAXLOVID?
As much as we all wish
PAXLOVID is an oral prescription medication that can treat adults and children 12 years and older weighing at least 88 pounds who:
have mild-to-moderate COVID-19, and
have had symptoms for 5 days or fewer, and
have a high-risk factor for progression to severe
PAXLOVID is not authorized for use as pre-exposure or post-exposure treatment for prevention of
Approximately 75% of American adults have at least one risk factor for progression to severe COVID-19 . You could be one of them.
Some of the most common risk factors for progression to severe
COVID-19 include:
- Age of 50+ years
-
Certain health conditions and diseases, such as heart disease and diabetes
- Being overweight or obese
- Mental health conditions
- Lifestyle factors, such as smoking
- Physical, mental, and developmental disabilities

Actor portrayals.
Some of the most common risk factors for progression to severe
COVID-19 include:
- Age of 50+ years
-
Certain health conditions and diseases, such as heart disease and diabetes
- Being overweight or obese
- Mental health conditions
- Lifestyle factors, such as smoking
- Physical, mental, and developmental disabilities
Despite the
†Other administrative fees may apply. The U.S. Government has purchased PAXLOVID from Pfizer and is continuing to make it available at no charge, regardless of insurance.
Despite the
†Other administrative fees may apply. The U.S. Government has purchased PAXLOVID from Pfizer and is continuing to make it available at no charge, regardless of insurance.
A trial compared the risk of COVID-19–related hospitalization or death in people treated with PAXLOVID vs placebo.
It’s important to understand the risks and possible side effects of PAXLOVID before starting treatment.
Be prepared for
If you’re at high risk for progression to severe
Be prepared for
If you’re at high risk for progression to severe
How to verify your tablets are authentic
PAXLOVID must be prescribed by a licensed healthcare professional and supplied by a government-approved pharmacy or medical facility.
Authentic PAXLOVID, from Pfizer Inc., will include the Pfizer name on the label and will be packaged in several aluminum push-through blister cards. Individual doses are not for sale. PAXLOVID will be packaged in a carton. The carton has a colorless, glossy coating that contains a repeated pattern of the Pfizer name and logo all over, and these repeating features are seen in a contrasting matte finish.
PAXLOVID consists of tablets for a 5-day oral treatment regimen, with morning and evening doses.
NOTE: If you are a patient with moderate kidney disease, you may receive a carton with daily blister cards that have been modified to ensure you receive the correct dose.
To help determine whether the tablets are authentic, look for specific text on each side of the tablets
Tablet | Embossed Text |
---|---|
nirmatrelvir | Front: 3CL | Back: PFE |
ritonavir, manufactured by AbbVie | Front: ![]() |
ritonavir, manufactured by Hetero | Front: H | Back: R9 |
ritnovair, manufacturer by AbbVie | Front: NK | Back: No text |
Pfizer is committed to patient safety and ensuring that people have accurate information about PAXLOVID, including how it is accessed and administered. We are actively monitoring for fraudulent offers of illegitimate PAXLOVID to protect patients from products that might be dangerous and lead to serious and life-threatening harm.
If you suspect the product you have received may be counterfeit, contact us at
For packaging options and information, see the Patient PAXLOVID Packaging Education Flashcard.
For packaging options and information, see the Patient PAXLOVID Packaging Education Flashcard.
For more information
Contact one of the following groups:
For medical information visit www.pfizermedicalinformation.com or
For general product inquiries